Dual Antiviral Therapy for Persistent Coronavirus Disease 2019 and Associated Organizing Pneumonia in an Immunocompromised Host
Caitlin A. Trottier, Beverly Wong, Rakhi Kohli, Cassidy Boomsma, Francis Magro, Sucharita Kher, Christina Anderlind, Yoav Golan
Abstract
The management of patients with prolonged viral shedding and coronavirus disease 2019 symptoms remains unclear. Combining antivirals, as practiced in other infections, is theoretically advantageous. We present a case of persistent, symptomatic severe acute respiratory syndrome coronavirus 2 infection and associated organizing pneumonia that was successfully treated with an extended course of combination antiviral therapy.
Topics & Concepts
MedicinePneumoniaCoronavirusViral pneumoniaCoronavirus disease 2019 (COVID-19)ImmunologyViral sheddingAntiviral therapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseVirologyRespiratory diseaseVirusInfectious disease (medical specialty)Internal medicineLungChronic hepatitisSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19